Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Oregon Compounding Centers Recalls Unexpired Sterile Products Due to Lack of Sterility Assurance

By Pharmaceutical Processing | October 10, 2014

Oregon Compounding Centers is voluntarily recalling certain unexpired human and veterinary sterile products to the consumer level due to lack of sterility assurance.

The company has not received any reports of product contamination or adverse events to date, but is issuing this voluntary recall out of an abundance of caution following a recent inspection which identified an issue with sterility assurance. If there is microbial contamination in products intended to be sterile, patients are at risk of serious infections which may be life threatening.

“We are fully cooperating with health officials,” said Denise Burnham, R.Ph., owner and pharmacist. “We deeply regret the impact this voluntary recall has on our customers, but patient safety is our highest priority.”

All recalled products have a label that includes the Creative Compounds name as well as a lot number. The recalled products were made from July 1, 2014 through September 22, 2014, and distributed to health care facilities, physicians, and patients in two states, Oregon and Washington.

The recall does not pertain to any non-sterile compounded medications prepared by the pharmacy.

All unexpired lots of the following sterile compounded products are subject to the recall:

Human Products

Medication

Lot Number

Discard Date

ALPROSTADIL 10 MCG/ML INJECTABLE

20140913@10

10/28/2014

ALPROSTADIL/LIDOCAINE HCL 20MCG/5MG/ML

20140902@17/1.25

10/17/2014

ASCORBIC ACID (B) 500 MG/ML INJECTABLE

20140821@17

10/20/2014

ASCORBIC ACID (PRES) 500 MG/ML INJECTABLE

20140827@34

10/26/2014

 

20140909@22

11/8/2014

 

20140912@2

11/11/2014

AVASTIN (SYRINGE-REPKG) 1.25MG/0.5ML INJECTABLE

20140715@13

11/3/2014

 

20140716@25

10/14/2014

 

20140717@7

10/15/2014

 

20140724@14

10/22/2014

 

20140724@15

10/22/2014

 

20140729@11

10/27/2014

 

20140801@17

10/30/2014

 

20140805@1

11/3/2014

 

20140807@13

11/5/2014

 

20140811@30

11/9/2014

 

20140813@10

11/11/2014

 

20140825@8

11/23/2014

 

20140904@46

12/3/2014

 

20140905@8

12/4/2014

 

20140909@12

12/8/2014

 

20140909@21

12/8/2014

 

20140912@30

12/11/2014

 

20140917@11

12/16/2014

 

20140917@9

12/16/2014

 

20140922@30

12/21/2014

 

20140814@15

11/12/2014

BEVACIZUMAB/DEXAMETHASONE (SYRINGE) 1.25/0.5 ML INJECTABLE

20140916@3

12/15/2014

CALCIUM CHLORIDE (COMPOUND) 100 MG/ML INJECTABLE

20140815@47

1/28/2015

CEFTAZIDIME (SYRINGE) 2.25/0.1ML INJECTABLE

20140905@33

10/20/2014

CHORIONIC GONADTROPIN (STERILE) 4000 UNITS POWDER

20140728@55

1/14/2015

 

20140915@14

3/8/2015

CHORIONIC GONADOTROPIN (STERILE) 5000 UNITS POWDER

20140909@5

3/8/2015

 

20140728@57

1/14/2015

CITRIC ACID/GLUCONOLACTONE MAGNES CARB (RENACIDIN) 66/1.98/31.77 MG/ML

20140908@2

10/23/2014

COPPER (SULF) 0.4 MG/ML INJECTABLE

20140919@21

11/3/2014

DEXAMETHASONE (AS SOD PHOS) 24 MG/ML INJECTABLE

20140903@10

10/18/2014

DEXPANTHENOL – (PRES) 250 MG/ML INJECTABLE

20140828@14

11/26/2014

DMPS-PRES FREE 50 MG/ML INJECTABLE

20140724@24/5

10/22/2014

 

20140724@25

10/22/2014

 

20140826@12

11/24/2014

EPINEPHRINE/WATER (PF) 1:1000 INJECTABLE

20140913@2

10/18/2014

ESTRADIOL CYPIONATE (COMPOUNDED/GRAPESEED OIL) 5 MG/ML INJECTABLE

20140828@15

10/12/2014

GANCICLOVIR (PF) 2MG/0.1ML INJECTABLE

20140916@16

10/31/2014

GANCICLOVIR (PF) 0.2MG/0.1ML INJECTABLE

20140911@9

10/26/2014

GENTAMICIN SULFATE 100MG/1000ML IRRIGATION

20140917@27

10/22/2014

GENTAMICIN SULFATE 480MG/1000ML IRRIG

20140912@29

10/16/2014

GLUTARALDEHYDE BUFFERED (POTASSIUM PHOSPHATE)

20140722@5

10/20/2014

 

20140723@45

10/21/2014

GLUTATHIONE (PRES) 100MG/ML INJECTABLE

20140721@25/00

11/18/2014

 

20140902@47

12/31/2014

GLUTATHIONE 100 MG/ML INJECTABLE

20140718@4

10/16/2014

HYALURONIDASE 240U/ML INJECTABLE

20140818@27

2/21/2015

HYDROXOCOBALAMIN-PF (B12) 1MG/ML INJ

20140717@6

10/15/2014

HYDROXOCOBALAMIN-PRES (B12) 1MG/ML INJ

20140729@18

10/27/2014

HYDROXYPROGESTERONE CAPROATE (SESAME OIL) 250MG/ML INJ

20140718@1/5

1/14/2015

 

20140813@25

2/9/2015

 

20140903@32

3/2/2015

LIDOCAINE HCL (REPKG-STERILE) 4% SOLUTION

20140815@12

2/16/2015

METHYCOBALAMIN (PF) 10MG/ML INJECTABLE

20140729@16/1

11/26/2014

METHYCOBALAMIN (PF) 1MG/ML INJECTABLE

20140722@2/2

1/18/2015

 

20140910@40/2

3/9/2015

METHYCOBALAMIN (PF) 20MG/ML INJECTABLE

20140718@2/0.3

1/14/2015

 

20140808@4/0.3

2/4/2015

 

20140902@36/1

3/1/2015

 

20140902@37/0.3

3/1/2015

 

20140912@22

3/11/2015

METHYCOBALAMIN (PRES) 1MG/ML INJECTABLE

20140715@2

10/13/2014

 

20140724@10

10/22/2014

 

20140812@14

11/1/2014

 

20140826@5

11/1/2014

MITOMYCIN 0.2MG/ML INJECTABLE

20140913@1

10/28/2014

MITOMYCIN 0.3MG/ML INJECTABLE

20140913@4

10/28/2014

OMNIPAQUE (REPKG) 300MGI/ML INJECTABLE

20140711@1

1/7/2015

 

20140814@22

2/10/2015

 

20140815@13

2/11/2015

PAPAV HCL/PHENTOL/PROSTAGL 12/1/10 INJECTABLE

20140827@30

10/11/2014

 

20140910@28

10/25/2014

 

20140917@2/1.25

11/1/2014

PAPAVERINE HCL/PHENTOLAMINE/ALPROSTADIL 21.82/0.91/45 INJ

20140722@16/1.7

12/3/2014

 

20140728@43/2

12/3/2014

PAPAVERINE HCL (PRES) 30 MG/ML INJECTABLE

20140903@14/1.25

10/18/2014

PAPAVERINE HCL/PHENTOLAMINE MES/ALPROSTADIL 22MG/0.8MG/8MCG INJ

20140901@3

10/19/2014

PAPAVERINE HCL/PHENTOLAMINE MES/PROSTAGLANDIN 23/0.96/19.23 ML INJ

20140708@30

12/2/2014

PAPAVERINE HCL/PHENTOLAMINE/PROSTAGLANDIN 27.70/0.45/45.45 INJ

20140912@25

10/27/2014

PAPAVERINE/PHENTOLAMINE/ALPROSTADIL 26.5/0.98/58.9 INJ

20140910@48/1.25

10/25/2014

 

20140911@11/1.25

10/26/2014

 

20140916@17/1.25

10/31/2014

PAPAVERINE/PHENTOLAMINE/PROSTAGLANDIN 17.16/0.57/19.45 INJ

20140728@39

12/3/2014

PAPAVERINE/PHENTOLAMINE/PROSTAGLANDIN 17.44/0.64/5.8 INJ

20140910@42

1/25/2015

PAPAVERINE/PHENTOLAMINE/PROSTAGLANDIN 17.64/0.58/5.88 INJ

20140828@4/1.7

10/15/2014

PREDNISOLONE SOD PHOS 1% OPTHAMALIC

20140902@22

10/17/2014

PROCAINE HCL (BUFF) 1% INJECTABLE

20140905@11

12/4/2014

PYRIDOXINE HCL (PRES)100 MG/ML INJECTABLE

20140715@18

10/13/2014

 

20140917@18

12/16/2014

SODIUM CHLORIDE INHALATION 7% SOLUTION

20140916@23

10/31/2014

TESTOSTERONE CYPIONATE (GRAPE SEED OIL/COMPOUNDED) 200MG/ML INJ

20140812@7

2/8/2015

 

20140910@41

3/9/2015

TESTOSTERONE CYPIONATE (SESAME OIL/CMPD)

20140714@51

1/10/2015

TOBRAMYCIN 480MG/1000 ML IRRIG

20140912@16

10/17/2014

TRIESENCE (SYRINGE-REPKG) 8MG/2.0ML INJ

20140909@6

10/24/2014

VANCOMYCIN (SYRINGE) 1MG/0.1ML INJ

20140905@32

10/20/2014

VITAMIN B COMPLEX(PRES) 100 INJ

20140811@5

10/16/2014

 

20140827@12

11/25/2014

Veterinary Products

Medication

Lot Number

Discard Date

APOMORPHINE HCL 3MG/ML INJECTABLE

20140818@37

11/16/2014

CYCLOSPORINE-E PLUS 2% OPHTHALMIC

20140702@12

12/29/2014

POLYSULF GLUCOSAMIN GLYCAN 10% INJECTABLE

20140820@7/30

11/18/2014

The company has begun notifying its customers by telephone, fax, electronic mail and/or regular mail of this recall. Users or recipients of these products should immediately discontinue use and return the recalled unexpired products. To return product or request assistance related to this recall, users should call 503-685-6111 or 877-585-6111, Monday through Friday, from 9:30 a.m. to 1 p.m. and 1:30 to 5:30 p.m. PDT.

Consumers should contact their physician or health care provider if they have experienced any problems that may be related to taking these drug products. Adverse reactions experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax

    Online: Complete and submit a report at www.fda.gov/medwatch/report.htm
    Regular Mail or Fax: Download form at www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and mail to address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

Related Articles Read More >

kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
Disposable syringe and American currency on black background
PBMs increasingly under fire in drug-pricing battle
Johnson & Johnson logo
Timeline: Navigating Johnson & Johnson’s talc lawsuits and their stock performance impact
pharmaceutical industry. Production line machine conveyor with glass bottles ampoules at factory
5 core trends in drug recalls: An analysis of 2022 and Q1 2023
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE